Vaccine 'Promising' for Delaying Relapse in KRAS-Mutated Pancreatic Cancer, CRC

(MedPage Today) -- An investigational therapeutic vaccine appeared to be effective in delaying relapse of KRAS-mutated pancreatic and colorectal cancer (CRC), according to results from the phase I AMPLIFY-201 study. Among 25 patients with pancreatic...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news